ATI LPN
Pharmacology and the Nursing Process 10th Edition Test Bank
Chapter 46 : Antineoplastic Drugs Part 2: Cell Cycle?Nonspecific Drugs and Miscellaneous Drugs Questions
Question 1 of 5
A patient is receiving a third session of chemotherapy with daunorubicin. The nurse will assess the patient for which signs of a potential severe toxic effect of this drug?
Correct Answer: C
Rationale: Cardiac toxicity may occur, so frequent checking of heart and breath sounds is necessary and daily weights need to be recorded (with reporting of an increase of 2 pounds or more in 24 hours or 5 pounds or more in 1 week).
Question 2 of 5
The nurse is hanging a new infusion bag of a chemotherapy drug, but the tubing becomes disconnected and a small amount of the solution drips onto the floor. Which action by the nurse is appropriate?
Correct Answer: C
Rationale: Special spill kits are required to clean up even the smallest chemotherapy spills. These precautions are necessary to protect the health care provider from the cytotoxic effects of these drugs.
Question 3 of 5
Just before the second course of chemotherapy, the laboratory calls to report that the patient's neutrophil count is 450 cells/m?³. The nurse expects that the oncologist will follow which course of treatment?
Correct Answer: D
Rationale: The normal range for neutrophils is above 1500 cells/m?³. If neutrophils are decreased to levels of less than 500 cells/m?³ (neutropenia), there is risk for severe infection. Chemotherapy will be held until the count returns toward normal levels.
Question 4 of 5
A female patient is receiving palliative therapy with androgen hormones as part of treatment for inoperable breast cancer. The nurse will discuss with the patient which potential body image changes that may occur as adverse effects?
Correct Answer: A
Rationale: Androgens used for cancer treatment, such as fluoxymesterone and testolactone, can cause menstrual irregularities, virilization of female, gynecomastia, hirsutism, acne, anxiety, headache, and nausea. The patient needs to be told of these effects before therapy begins.
Question 5 of 5
During chemotherapy, a patient develops severe diarrhea caused by a vasoactive intestinal peptide-secreting tumor (VIPoma). The nurse expects to administer which drug for this problem?
Correct Answer: C
Rationale: Octreotide (Sandostatin) is used for the management of a cancer-related condition called carcinoid crisis and treatment of the severe diarrhea caused by vasoactive intestinal peptide-secreting tumors.